European Vaccine Manufacturers (EVM)

EVM (European Vaccine Manufacturers) is a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the European pharmaceutical industry.

EVM brings together 9 company members. The group was established in 1991 in order to promote a favourable climate for expanded vaccine protection and improved vaccine coverage in Europe, and to help sustain the innovative R & D capability of vaccine manufacturers in Europe.

The Mission of EVM is to:

• to create a supportive environment for improved vaccine protection and coverage in the interest of individual and community public health
  
  
• to promote vaccine R & D to meet new challenges for innovative vaccine applications against infectious and other types of diseases
  
  
• to foster a favourable policy climate for the vaccine industry in Europe to bring new vaccines to the world
  
  

Did you know that the European vaccine industry:

• is the largest supplier of vaccines in the world, producing the majority of vaccine doses in Europe
  
  
• is the largest supplier to UNICEF of vital paediatric vaccines,including polio vaccines
  
  
• has developed vaccines specifically designed for the needs of developing countries (e.g., combined paediatric vaccines against diphtheria, tetanus, pertussis, hepatitis B, and invasive Hib disease)
  
  
• is working in collaboration with the public sector in joint R&D activities and in clinical trials partnerships to develop vaccines against diseases that particularly burden developing countries (e.g., denguefever, leishmaniasis, rotavirus, HIV, malaria and tuberculosis, among others)
  
  
• contributes significantly to Research & Development with over half of all global vaccine R&D being carried out in Europe by EVM member companies
  
  
• has production facilities not only in Europe but across the globe through international collaboration and joint ventures
  
  
• submits its novel products to a centralised procedure to obtain EU licensing (e.g. all hepatitis B vaccines, hepatitis B-containing combination vaccines, as well as the pneumococcal conjugate vaccines, among others)
  
  

For more information on Ressources and Initiatives supported by EVM as well as membership application process can be easily found on their corporate website:www.evm-vaccines.org